Formica V - Search Results

1

Formica V, Nardecchia A, Morelli C, Lucchetti J, Giuliano G, Renzi N, Gallo C, Pellegrino R, Massimiliani V, Serci C, Russo A, Patrikidou A, Arkenau HT, Maiorino L, Tesauro M, Roselli M. Formica V, et al. Ann Palliat Med. 2021 Apr;10(4):4252-4261. doi: 10.21037/apm-20-2194. Epub 2021 Apr 1. Ann Palliat Med. 2021. PMID: 33832305 Free article.

2

Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer.

Ferroni P, Palmirotta R, Spila A, Martini F, Formica V, Portarena I, Del Monte G, Buonomo O, Roselli M, Guadagni F. Ferroni P, et al. Among authors: formica v. Oncology. 2006;71(3-4):176-84. doi: 10.1159/000106072. Epub 2007 Jul 23. Oncology. 2006. PMID: 17652942

3

Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.

Guadagni F, Ferroni P, Palmirotta R, Del Monte G, Formica V, Roselli M. Guadagni F, et al. Among authors: formica v. Anticancer Res. 2007 Sep-Oct;27(5A):3147-62. Anticancer Res. 2007. PMID: 17970056 Free article. Review.

4

The Medical Care Continuity (MCC) project. A pilot study of video-assisted home care within the eTEN European Community program. The Italian experience.

Formica V, Fossile E, Pellegrino R, Fatale M, Mari M, Rabuffetti M, Benedetto FR, Visconti G, Bollero E, Roselli M. Formica V, et al. Support Care Cancer. 2009 May;17(5):471-8. doi: 10.1007/s00520-008-0559-1. Epub 2008 Dec 17. Support Care Cancer. 2009. PMID: 19089459

5

Thromboembolic events in patients treated with anti-angiogenic drugs.

Ferroni P, Formica V, Roselli M, Guadagni F. Ferroni P, et al. Among authors: formica v. Curr Vasc Pharmacol. 2010 Jan;8(1):102-13. doi: 10.2174/157016110790226660. Curr Vasc Pharmacol. 2010. PMID: 19485903 Free article. Review.

6

Prognostic significance of serum adipokine levels in colorectal cancer patients.

Guadagni F, Roselli M, Martini F, Spila A, Riondino S, D'Alessandro R, Del Monte G, Formica V, Laudisi A, Portarena I, Palmirotta R, Ferroni P. Guadagni F, et al. Among authors: formica v. Anticancer Res. 2009 Aug;29(8):3321-7. Anticancer Res. 2009. PMID: 19661351 Free article.

7

A novel K-ras mutation in colorectal cancer. A case report and literature review.

Palmirotta R, Savonarola A, Formica V, Ludovici G, Del Monte G, Roselli M, Guadagni F. Palmirotta R, et al. Among authors: formica v. Anticancer Res. 2009 Aug;29(8):3369-74. Anticancer Res. 2009. PMID: 19661358 Free article. Review.

8

Role of CA19.9 in predicting bevacizumab efficacy for metastatic colorectal cancer patients.

Formica V, Massara MC, Portarena I, Fiaschetti V, Grenga I, Del Vecchio Blanco G, Sileri P, Tosetto L, Skoulidis F, Pallone F, Roselli M. Formica V, et al. Cancer Biomark. 2009;5(4):167-75. doi: 10.3233/CBM-2009-0101. Cancer Biomark. 2009. PMID: 19729826

9

Caregiver distress in the early phases of cancer.

Pellegrino R, Formica V, Portarena I, Mariotti S, Grenga I, Del Monte G, Roselli M. Pellegrino R, et al. Among authors: formica v. Anticancer Res. 2010 Nov;30(11):4657-63. Anticancer Res. 2010. PMID: 21115920

10

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab.

Formica V, Palmirotta R, Del Monte G, Savonarola A, Ludovici G, De Marchis ML, Grenga I, Schirru M, Guadagni F, Roselli M. Formica V, et al. Int J Colorectal Dis. 2011 Feb;26(2):143-51. doi: 10.1007/s00384-010-1108-1. Epub 2010 Dec 29. Int J Colorectal Dis. 2011. PMID: 21188390

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page